Scientific article
English

Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation

Published in

Transplantation proceedings, vol. 37, no. 2, p. 1326-1327

Publication date

2005

Abstract

Islet transplantation is gaining recognition as a therapeutic option for selected diabetic patients. The immunosuppressive regimen based on sirolimus/low-dose tacrolimus is considered a major breakthrough that allowed considerable improvement in graft survival. A high incidence of side effects associated with such a regimen has been reported in the literature, but this immunosuppressive protocol is generally considered safe or even protective to the kidney. Herein, we analyze the impact of the sirolimus/low-dose tacrolimus-based protocol on kidney function.

Keywords

  • Creatinine/metabolism
  • Diabetes Mellitus, Type 1/drug therapy/surgery
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents/therapeutic use
  • Immunosuppressive Agents/therapeutic use
  • Insulin/therapeutic use
  • Islets of Langerhans Transplantation/immunology/methods/physiology
  • Kidney Function Tests
  • Sirolimus/therapeutic use
  • Tacrolimus/therapeutic use
  • Treatment Outcome

Citation (ISO format)

ANDRES, Axel et al. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation. In: Transplantation proceedings, 2005, vol. 37, n° 2, p. 1326–1327. doi: 10.1016/j.transproceed.2004.12.040

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0041-1345
820views
0downloads

Technical informations

Creation

30/05/2014 10:49:00

First validation

30/05/2014 10:49:00

Update

13/10/2025 22:44:05

Status update

14/03/2023 21:16:57

Last indexation

04/02/2026 14:48:00
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated